Skip to main content
Erschienen in: World Journal of Pediatrics 5/2023

10.01.2023 | COVID-19 | Original Article

Altered gut microbiota composition in children and their caregivers infected with the SARS-CoV-2 Omicron variant

verfasst von: Yi-Zhong Wang, Jian-Guo Zhou, Yan-Ming Lu, Hui Hu, Fang-Fei Xiao, Ting Ge, Xing Wang, Lu Zheng, Lian-Hu Yu, Jun Le, Hui Yu, Guang-Jun Yu, Qiang Xia, Ting Zhang, Wen-Hao Zhou

Erschienen in: World Journal of Pediatrics | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Gut microbiota alterations have been implicated in the pathogenesis of coronavirus disease 2019 (COVID-19). This study aimed to explore gut microbiota changes in a prospective cohort of COVID-19 children and their asymptomatic caregivers infected with the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) Omicron variant.

Methods

A total of 186 participants, including 59 COVID-19 children, 50 asymptomatic adult caregivers, 52 healthy children (HC), and 25 healthy adults (HA), were recruited between 15 April and 31 May 2022. The gut microbiota composition was determined by 16S rRNA gene sequencing in fecal samples collected from the participants. Gut microbiota functional profiling was performed by using Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt) software.

Results

The gut microbiota analysis of beta diversity revealed that the fecal microbial community of COVID-19 children remained far distantly related to HC. The relative abundances of the phyla Actinobacteria and Firmicutes were decreased, whereas Bacteroidetes, Proteobacteria, and Verrucomicrobiota were increased in COVID-19 children. Feces from COVID-19 children exhibited notably lower abundances of the genera Blautia, Bifidobacterium, Fusicatenibacter, Streptococcus, and Romboutsia and higher abundances of the genera Prevotella, Lachnoclostridium, Escherichia-Shigella, and Bacteroides than those from HC. The enterotype distributions of COVID-19 children were characterized by a high prevalence of enterotype Bacteroides. Similar changes in gut microbiota compositions were observed in asymptomatic caregivers. Furthermore, the microbial metabolic activities of KEGG (Kyoto Encyclopedia of Genes and Genomes) and COG (cluster of orthologous groups of proteins) pathways were perturbed in feces from subjects infected with the SARS-CoV-2 Omicron variant.

Conclusion

Our data reveal altered gut microbiota compositions in both COVID-19 children and their asymptomatic caregivers infected with the SARS-CoV-2 Omicron variant, which further implicates the critical role of gut microbiota in COVID-19 pathogenesis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Tao K, Tzou PL, Nouhin J, Gupta RK, de Oliveira T, Kosakovsky Pond SL, et al. The biological and clinical significance of emerging SARS-CoV-2 variants. Nat Rev Genet. 2021;22:757–73.CrossRefPubMedPubMedCentral Tao K, Tzou PL, Nouhin J, Gupta RK, de Oliveira T, Kosakovsky Pond SL, et al. The biological and clinical significance of emerging SARS-CoV-2 variants. Nat Rev Genet. 2021;22:757–73.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Mohiuddin M, Kasahara K. Investigating the aggressiveness of the COVID-19 Omicron variant and suggestions for possible treatment options. Respir Med. 2022;191:106716.CrossRefPubMed Mohiuddin M, Kasahara K. Investigating the aggressiveness of the COVID-19 Omicron variant and suggestions for possible treatment options. Respir Med. 2022;191:106716.CrossRefPubMed
5.
Zurück zum Zitat Dyer O. Covid-19: Omicron is causing more infections but fewer hospital admissions than delta, South African data show. BMJ. 2021;375:n3104.CrossRefPubMed Dyer O. Covid-19: Omicron is causing more infections but fewer hospital admissions than delta, South African data show. BMJ. 2021;375:n3104.CrossRefPubMed
6.
Zurück zum Zitat Lupala CS, Ye Y, Chen H, Su XD, Liu H. Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor. Biochem Biophys Res Commun. 2022;590:34–41.CrossRefPubMed Lupala CS, Ye Y, Chen H, Su XD, Liu H. Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor. Biochem Biophys Res Commun. 2022;590:34–41.CrossRefPubMed
7.
Zurück zum Zitat Cao Y, Wang J, Jian F, Xiao T, Song W, Yisimayi A, et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature. 2022;602:657–63.CrossRefPubMed Cao Y, Wang J, Jian F, Xiao T, Song W, Yisimayi A, et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature. 2022;602:657–63.CrossRefPubMed
8.
Zurück zum Zitat Cao Y, Yisimayi A, Jian F, Song W, Xiao T, Wang L, et al. BA.2.121, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature. 2022;608:593–602.CrossRefPubMedPubMedCentral Cao Y, Yisimayi A, Jian F, Song W, Xiao T, Wang L, et al. BA.2.121, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature. 2022;608:593–602.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology. 2020;159:81–95.CrossRefPubMed Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology. 2020;159:81–95.CrossRefPubMed
10.
Zurück zum Zitat Lamers MM, Beumer J, van der Vaart J, Knoops K, Puschhof J, Breugem TI, et al. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020;369:50–4.CrossRefPubMed Lamers MM, Beumer J, van der Vaart J, Knoops K, Puschhof J, Breugem TI, et al. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020;369:50–4.CrossRefPubMed
11.
Zurück zum Zitat Jin X, Lian JS, Hu JH, Gao J, Zheng L, Zhang YM, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020;69:1002–9.CrossRefPubMed Jin X, Lian JS, Hu JH, Gao J, Zheng L, Zhang YM, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020;69:1002–9.CrossRefPubMed
12.
Zurück zum Zitat Xu Y, Li X, Zhu B, Liang H, Fang C, Gong Y, et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. 2020;26:502–5.CrossRefPubMedPubMedCentral Xu Y, Li X, Zhu B, Liang H, Fang C, Gong Y, et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. 2020;26:502–5.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Wang B, Zhang L, Wang Y, Dai T, Qin Z, Zhou F, et al. Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2022;7:143.CrossRefPubMedPubMedCentral Wang B, Zhang L, Wang Y, Dai T, Qin Z, Zhou F, et al. Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2022;7:143.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Yeoh YK, Zuo T, Lui GC, Zhang F, Liu Q, Li AY, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698–706.CrossRefPubMed Yeoh YK, Zuo T, Lui GC, Zhang F, Liu Q, Li AY, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698–706.CrossRefPubMed
15.
16.
Zurück zum Zitat Zhou JG, Lu YM, Wang LB, Yu H, Zhang T, Chen YW, et al. Pediatric patients in the new wave of SARS-CoV-2 infection in Shanghai, China. World J Pediatr. 2022;18:579–81.CrossRefPubMedPubMedCentral Zhou JG, Lu YM, Wang LB, Yu H, Zhang T, Chen YW, et al. Pediatric patients in the new wave of SARS-CoV-2 infection in Shanghai, China. World J Pediatr. 2022;18:579–81.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13:581–3.CrossRefPubMedPubMedCentral Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13:581–3.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Douglas GM, Maffei VJ, Zaneveld JR, Yurgel SN, Brown JR, Taylor CM, et al. PICRUSt2 for prediction of metagenome functions. Nat Biotechnol. 2020;38:685–8.CrossRefPubMedPubMedCentral Douglas GM, Maffei VJ, Zaneveld JR, Yurgel SN, Brown JR, Taylor CM, et al. PICRUSt2 for prediction of metagenome functions. Nat Biotechnol. 2020;38:685–8.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Schlechte J, Skalosky I, Geuking MB, McDonald B. Long-distance relationships-regulation of systemic host defense against infections by the gut microbiota. Mucosal Immunol. 2022;15:809–18.CrossRefPubMed Schlechte J, Skalosky I, Geuking MB, McDonald B. Long-distance relationships-regulation of systemic host defense against infections by the gut microbiota. Mucosal Immunol. 2022;15:809–18.CrossRefPubMed
21.
Zurück zum Zitat Zama D, Totaro C, Biscardi L, Rocca A, Turroni S, Brigidi P, et al. The relationship between gut microbiota and respiratory tract infections in childhood: a narrative review. Nutrients. 2022;14:2992.CrossRefPubMedPubMedCentral Zama D, Totaro C, Biscardi L, Rocca A, Turroni S, Brigidi P, et al. The relationship between gut microbiota and respiratory tract infections in childhood: a narrative review. Nutrients. 2022;14:2992.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Li L, Wang F, Liu Y, Gu F. Intestinal microbiota dysbiosis in children with recurrent respiratory tract infections. Microb Pathog. 2019;136:103709.CrossRefPubMed Li L, Wang F, Liu Y, Gu F. Intestinal microbiota dysbiosis in children with recurrent respiratory tract infections. Microb Pathog. 2019;136:103709.CrossRefPubMed
23.
Zurück zum Zitat Hasegawa K, Linnemann RW, Mansbach JM, Ajami NJ, Espinola JA, Petrosino JF, et al. The fecal microbiota profile and bronchiolitis in infants. Pediatrics. 2016;138:e20160218.CrossRefPubMedPubMedCentral Hasegawa K, Linnemann RW, Mansbach JM, Ajami NJ, Espinola JA, Petrosino JF, et al. The fecal microbiota profile and bronchiolitis in infants. Pediatrics. 2016;138:e20160218.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Antunes KH, Stein RT, Franceschina C, da Silva EF, de Freitas DN, Silveira J, et al. Short-chain fatty acid acetate triggers antiviral response mediated by RIG-I in cells from infants with respiratory syncytial virus bronchiolitis. EBioMedicine. 2022;77:103891.CrossRefPubMedPubMedCentral Antunes KH, Stein RT, Franceschina C, da Silva EF, de Freitas DN, Silveira J, et al. Short-chain fatty acid acetate triggers antiviral response mediated by RIG-I in cells from infants with respiratory syncytial virus bronchiolitis. EBioMedicine. 2022;77:103891.CrossRefPubMedPubMedCentral
25.
26.
Zurück zum Zitat Shi DW, Wang DM, Ning LH, Li J, Dong Y, Zhang ZK, et al. Using 16S rDNA sequencing technology to preliminarily analyze intestinal flora in children with Mycoplasma pneumoniae pneumonia. Biomed Environ Sci. 2022;35:528–37.PubMed Shi DW, Wang DM, Ning LH, Li J, Dong Y, Zhang ZK, et al. Using 16S rDNA sequencing technology to preliminarily analyze intestinal flora in children with Mycoplasma pneumoniae pneumonia. Biomed Environ Sci. 2022;35:528–37.PubMed
27.
Zurück zum Zitat Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterol. 2020;159:944–55.e8.CrossRef Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterol. 2020;159:944–55.e8.CrossRef
28.
Zurück zum Zitat Xu R, Liu P, Zhang T, Wu Q, Zeng M, Ma Y, et al. Progressive deterioration of the upper respiratory tract and the gut microbiomes in children during the early infection stages of COVID-19. J Genet Genom. 2021;48:803–14.CrossRef Xu R, Liu P, Zhang T, Wu Q, Zeng M, Ma Y, et al. Progressive deterioration of the upper respiratory tract and the gut microbiomes in children during the early infection stages of COVID-19. J Genet Genom. 2021;48:803–14.CrossRef
29.
Zurück zum Zitat Nashed L, Mani J, Hazrati S, Stern DB, Subramanian P, Mattei L, et al. Gut microbiota changes are detected in asymptomatic very young children with SARS-CoV-2 infection. Gut. 2022;71:2371–3.CrossRefPubMed Nashed L, Mani J, Hazrati S, Stern DB, Subramanian P, Mattei L, et al. Gut microbiota changes are detected in asymptomatic very young children with SARS-CoV-2 infection. Gut. 2022;71:2371–3.CrossRefPubMed
30.
Zurück zum Zitat Suskun C, Kilic O, Yilmaz Ciftdogan D, Guven S, Karbuz A, OzkayaParlakay A, et al. Intestinal microbiota composition of children with infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and multisystem inflammatory syndrome (MIS-C). Eur J Pediatr. 2022;181:3175–91.CrossRefPubMedPubMedCentral Suskun C, Kilic O, Yilmaz Ciftdogan D, Guven S, Karbuz A, OzkayaParlakay A, et al. Intestinal microbiota composition of children with infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and multisystem inflammatory syndrome (MIS-C). Eur J Pediatr. 2022;181:3175–91.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207–14.CrossRef Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207–14.CrossRef
32.
Zurück zum Zitat Zuo T, Liu Q, Zhang F, Lui GC, Tso EY, Yeoh YK, et al. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut. 2021;70:276–84.PubMed Zuo T, Liu Q, Zhang F, Lui GC, Tso EY, Yeoh YK, et al. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut. 2021;70:276–84.PubMed
33.
Zurück zum Zitat Grenga L, Pible O, Miotello G, Culotta K, Ruat S, Roncato MA, et al. Taxonomical and functional changes in COVID-19 faecal microbiome could be related to SARS-CoV-2 faecal load. Environ Microbiol. 2022;24:4299–316.CrossRefPubMedPubMedCentral Grenga L, Pible O, Miotello G, Culotta K, Ruat S, Roncato MA, et al. Taxonomical and functional changes in COVID-19 faecal microbiome could be related to SARS-CoV-2 faecal load. Environ Microbiol. 2022;24:4299–316.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Vestad B, Ueland T, Lerum TV, Dahl TB, Holm K, Barratt-Due A, et al. Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations. J Intern Med. 2022;291:801–12.CrossRefPubMedPubMedCentral Vestad B, Ueland T, Lerum TV, Dahl TB, Holm K, Barratt-Due A, et al. Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations. J Intern Med. 2022;291:801–12.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Ng SC, Peng Y, Zhang L, Mok CK, Zhao S, Li A, et al. Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events. Gut. 2022;71:1106–16.CrossRefPubMed Ng SC, Peng Y, Zhang L, Mok CK, Zhao S, Li A, et al. Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events. Gut. 2022;71:1106–16.CrossRefPubMed
Metadaten
Titel
Altered gut microbiota composition in children and their caregivers infected with the SARS-CoV-2 Omicron variant
verfasst von
Yi-Zhong Wang
Jian-Guo Zhou
Yan-Ming Lu
Hui Hu
Fang-Fei Xiao
Ting Ge
Xing Wang
Lu Zheng
Lian-Hu Yu
Jun Le
Hui Yu
Guang-Jun Yu
Qiang Xia
Ting Zhang
Wen-Hao Zhou
Publikationsdatum
10.01.2023
Verlag
Springer Nature Singapore
Schlagwort
COVID-19
Erschienen in
World Journal of Pediatrics / Ausgabe 5/2023
Print ISSN: 1708-8569
Elektronische ISSN: 1867-0687
DOI
https://doi.org/10.1007/s12519-022-00659-6

Weitere Artikel der Ausgabe 5/2023

World Journal of Pediatrics 5/2023 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.